Next Breath & WFF 2021
From Water to Air; Scientific Pathways towards a Clearer, Cleaner Future.
Gerhard Scheuch
CEO, GS Bio-Inhalation



Talk Title — Exhaled Aerosols and Virus Infection










"It is important to understand, that even quiet breathing is enough to generate aerosols in the deep lung which are exhaled. A viral infection intensifies this process so that several orders of magnitude more aerosols are produced and exhaled. In that way a person becomes a ‘virus superemitter’ and may cause a cluster infection.”

Gerhard Scheuch 
Gerhard is a Bio Physicist with many years of experience in Aerosol Medicine and Pulmonary Drug Delivery, and involved in different Pharmaceutical Developments in Inhalation Therapy. He was a regulatory Expert at EMA and serves on a number of international life science boards.. He was the President of the International Society of Aerosols in Medicine (ISAM) from 2009-2011, and served as board member at ISAM 1999-2013. Gerhard is the founder and CEO of Activaero a drug development company until acquisition by Vectura Group plc in March 2014. He is also the founder of Inamed, a CRO specialized in the field of respiratory diseases and Ventaleon, which is a project company using inhaled LASAG to treat different respiratory viral infections. 
Specialties: Pulmonary Deposition of inhaled Aerosols, In vitro in vivo correlation. Deposition measurements and modelling. Inhalation Product development. 
 if you have missed any of our posters
you can find them on website, and on Facebook
ALL MEDIA INQUIRIES, INTERVIEWS & PHOTO REQUESTS